Hepatitis C treatment in Poland – new drug concept test
Market research agency
One of the leading global pharmaceutical company was planning to introduce in the market new product for the treatment of Hepatitis C. They were interested in examining the uptake and adoption of their potential product across different patient types.
We have conducted a series of in-depth interviews (IDIs) with healthcare professionals who manage patients with Hepatitis C in Poland. We spoke to gastroenterologists, hepatologists and infectious diseases specialists. During each interview we discussed the Hepatitis C treatment landscape and presented product information for three products in development.
Value for the client
Applied methodology allowed us to gather impressions of agents in development for the treatment of Hepatitis C. We managed to identify the most important advantages of the products and factors that could pose a barrier to the agents. Discussions helped us understand how therapy may evolve in the coming years. Research results allowed our client to better understand local market and thus prepare more effective launch strategy for their product.
- New reimbursement act – a survey of pharmaceutical companies
- Healthcare service offer survey
- Marketing communication test for a paediatric vaccine in Poland
- OTC market in Poland
- Biological and biosimilars drug market in Poland
- Private healthcare market in Central Europe